Skip to content
healthcare.dev

Risedronate Sodium

NDC 33342-108, Risedronate Sodium, tablet, film coated, from Macleods Pharmaceuticals Limited.

Product NDC
33342-108
Status
Listed
Labeler
Macleods Pharmaceuticals Limited
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA203533
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/33342-108 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RISEDRONATE SODIUM30 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
33342-108-06333420108063 BLISTER PACK in 1 CARTON (33342-108-06) / 10 TABLET, FILM COATED in 1 BLISTER PACK
33342-108-073334201080730 TABLET, FILM COATED in 1 CONTAINER (33342-108-07)
33342-108-1533342010815500 TABLET, FILM COATED in 1 CONTAINER (33342-108-15)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/62aff8d6-a2f7-4c7e-a102-c70105ac3792

Use it

Look up 33342-108 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/33342-108 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 33342-108. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.